Hainan Huluwa Pharmaceutical Group Co Ltd (605199) — Free Cash Flow Generation Index
Hainan Huluwa Pharmaceutical Group Co Ltd (605199) has a Free Cash Flow Generation Index of 0.79x as of September 2025. Free cash flow of CN¥35.19 Million represents 1% of operating cash flow (CN¥44.34 Million). Explore 605199 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hainan Huluwa Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (2016–2025)
Historical FCF Generation Index trend for Hainan Huluwa Pharmaceutical Group Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see 605199 operating cash flow.
Annual Free Cash Flow Generation for Hainan Huluwa Pharmaceutical Group Co Ltd (2016–2025)
Year-by-year Free Cash Flow Generation Index for Hainan Huluwa Pharmaceutical Group Co Ltd. Check Hainan Huluwa Pharmaceutical Group Co Lt (605199) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | CN¥53.18 Million | CN¥136.85 Million | CN¥83.67 Million | ▲ +102.4% |
| 2023 | -16.32x | CN¥-460.95 Million | CN¥28.25 Million | CN¥489.20 Million | ▼ -2435.4% |
| 2022 | -0.64x | CN¥-153.61 Million | CN¥238.71 Million | CN¥392.32 Million | ▼ -87.7% |
| 2021 | -0.34x | CN¥-35.14 Million | CN¥102.48 Million | CN¥137.62 Million | ▲ +98.0% |
| 2020 | -17.01x | CN¥-56.12 Million | CN¥3.30 Million | CN¥59.42 Million | ▼ -2953.6% |
| 2019 | 0.60x | CN¥86.12 Million | CN¥144.51 Million | CN¥58.40 Million | ▲ +146.2% |
| 2018 | -1.29x | CN¥-41.02 Million | CN¥31.80 Million | CN¥72.82 Million | ▼ -71.6% |
| 2017 | -0.75x | CN¥-67.62 Million | CN¥89.96 Million | CN¥157.58 Million | ▼ -303.6% |
| 2016 | 0.37x | CN¥23.98 Million | CN¥64.96 Million | CN¥40.99 Million | — |